

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 8.31500267 |
| 2 | doxorubicin metabolic process (GO:0044598) | 8.31500267 |
| 3 | daunorubicin metabolic process (GO:0044597) | 8.31500267 |
| 4 | cellular glucuronidation (GO:0052695) | 7.49893082 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.43588063 |
| 6 | exogenous drug catabolic process (GO:0042738) | 7.32561210 |
| 7 | glucuronate metabolic process (GO:0019585) | 7.31144889 |
| 8 | uronic acid metabolic process (GO:0006063) | 7.31144889 |
| 9 | drug catabolic process (GO:0042737) | 6.90636710 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 6.26113260 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.87351494 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 5.86044011 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.86044011 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 5.66735141 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.66735141 |
| 16 | primary alcohol catabolic process (GO:0034310) | 5.60047379 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 5.42736288 |
| 18 | drug metabolic process (GO:0017144) | 5.34532626 |
| 19 | desmosome organization (GO:0002934) | 5.25267191 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.22780886 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.16792171 |
| 22 | bile acid biosynthetic process (GO:0006699) | 5.06874526 |
| 23 | bile acid metabolic process (GO:0008206) | 4.98544896 |
| 24 | intestinal cholesterol absorption (GO:0030299) | 4.92644911 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 4.90182818 |
| 26 | flavonoid metabolic process (GO:0009812) | 4.89818106 |
| 27 | urea metabolic process (GO:0019627) | 4.79259887 |
| 28 | glycoside metabolic process (GO:0016137) | 4.77198726 |
| 29 | phospholipid efflux (GO:0033700) | 4.73615200 |
| 30 | fibrinolysis (GO:0042730) | 4.71833433 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 4.71586962 |
| 32 | viral transcription (GO:0019083) | 4.68470230 |
| 33 | regulation of water loss via skin (GO:0033561) | 4.68278280 |
| 34 | establishment of skin barrier (GO:0061436) | 4.67549375 |
| 35 | ribosomal small subunit assembly (GO:0000028) | 4.63280922 |
| 36 | bile acid and bile salt transport (GO:0015721) | 4.62318438 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.59193743 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.59093944 |
| 39 | translational termination (GO:0006415) | 4.54501322 |
| 40 | interferon-gamma secretion (GO:0072643) | 4.48153903 |
| 41 | oxidative demethylation (GO:0070989) | 4.45242293 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.38681709 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.38681709 |
| 44 | ethanol oxidation (GO:0006069) | 4.34085226 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.33776291 |
| 46 | ribosomal small subunit biogenesis (GO:0042274) | 4.33325775 |
| 47 | complement activation, alternative pathway (GO:0006957) | 4.32234494 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 4.22636410 |
| 49 | sphingoid metabolic process (GO:0046519) | 4.18139674 |
| 50 | regulation of complement activation (GO:0030449) | 4.17522517 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.15229206 |
| 52 | heme transport (GO:0015886) | 4.15101391 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14657914 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.00898930 |
| 55 | negative regulation of lipase activity (GO:0060192) | 3.96453669 |
| 56 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.96428724 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.96420008 |
| 58 | translational elongation (GO:0006414) | 3.95526850 |
| 59 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.95518551 |
| 60 | maturation of SSU-rRNA (GO:0030490) | 3.95514973 |
| 61 | acylglycerol homeostasis (GO:0055090) | 3.95486599 |
| 62 | triglyceride homeostasis (GO:0070328) | 3.95486599 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.95290405 |
| 64 | protein carboxylation (GO:0018214) | 3.95290405 |
| 65 | urea cycle (GO:0000050) | 3.95207496 |
| 66 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.95082090 |
| 67 | hormone catabolic process (GO:0042447) | 3.92978613 |
| 68 | quinone metabolic process (GO:1901661) | 3.91954285 |
| 69 | protein targeting to ER (GO:0045047) | 3.85984044 |
| 70 | cotranslational protein targeting to membrane (GO:0006613) | 3.84726401 |
| 71 | cholesterol efflux (GO:0033344) | 3.82598232 |
| 72 | formation of translation preinitiation complex (GO:0001731) | 3.79411300 |
| 73 | S-adenosylmethionine metabolic process (GO:0046500) | 3.78903598 |
| 74 | ribosomal large subunit biogenesis (GO:0042273) | 3.76231481 |
| 75 | drug transmembrane transport (GO:0006855) | 3.74310398 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.73961612 |
| 77 | serine family amino acid catabolic process (GO:0009071) | 3.70514689 |
| 78 | xenobiotic catabolic process (GO:0042178) | 3.69945534 |
| 79 | negative regulation of hemostasis (GO:1900047) | 3.69852093 |
| 80 | negative regulation of blood coagulation (GO:0030195) | 3.69852093 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 3.69847364 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 3.69847364 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.69847364 |
| 84 | translational initiation (GO:0006413) | 3.69333549 |
| 85 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.67384130 |
| 86 | viral life cycle (GO:0019058) | 3.65245180 |
| 87 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.63834352 |
| 88 | amino sugar catabolic process (GO:0046348) | 3.63595626 |
| 89 | protein localization to endoplasmic reticulum (GO:0070972) | 3.62570992 |
| 90 | sphingosine metabolic process (GO:0006670) | 3.61107701 |
| 91 | protein-lipid complex remodeling (GO:0034368) | 3.60868730 |
| 92 | macromolecular complex remodeling (GO:0034367) | 3.60868730 |
| 93 | plasma lipoprotein particle remodeling (GO:0034369) | 3.60868730 |
| 94 | arginine metabolic process (GO:0006525) | 3.60266696 |
| 95 | ethanol metabolic process (GO:0006067) | 3.56586129 |
| 96 | L-ascorbic acid metabolic process (GO:0019852) | 3.56075317 |
| 97 | alkaloid metabolic process (GO:0009820) | 3.54995536 |
| 98 | glycine metabolic process (GO:0006544) | 3.54478640 |
| 99 | negative regulation of coagulation (GO:0050819) | 3.54203861 |
| 100 | intestinal absorption (GO:0050892) | 3.53872491 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 3.52026426 |
| 102 | xenobiotic metabolic process (GO:0006805) | 3.50693262 |
| 103 | cellular protein complex disassembly (GO:0043624) | 3.49713280 |
| 104 | intestinal epithelial cell development (GO:0060576) | 3.49269089 |
| 105 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.48765991 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.44815248 |
| 107 | regulation of plasminogen activation (GO:0010755) | 3.44255589 |
| 108 | cellular aldehyde metabolic process (GO:0006081) | 3.43948068 |
| 109 | cysteine metabolic process (GO:0006534) | 3.43623163 |
| 110 | retinal metabolic process (GO:0042574) | 3.41625716 |
| 111 | diol metabolic process (GO:0034311) | 3.41557055 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40629333 |
| 113 | negative regulation of wound healing (GO:0061045) | 3.40400815 |
| 114 | phospholipid scrambling (GO:0017121) | 3.40364918 |
| 115 | serine family amino acid metabolic process (GO:0009069) | 3.30254096 |
| 116 | response to nitrosative stress (GO:0051409) | 3.29835009 |
| 117 | primary alcohol metabolic process (GO:0034308) | 3.28750406 |
| 118 | drug transport (GO:0015893) | 3.25268809 |
| 119 | regulation of chemokine secretion (GO:0090196) | 3.23614436 |
| 120 | vitamin biosynthetic process (GO:0009110) | 3.23160765 |
| 121 | coenzyme catabolic process (GO:0009109) | 3.22252459 |
| 122 | L-methionine salvage (GO:0071267) | 3.19608810 |
| 123 | L-methionine biosynthetic process (GO:0071265) | 3.19608810 |
| 124 | amino acid salvage (GO:0043102) | 3.19608810 |
| 125 | tyrosine metabolic process (GO:0006570) | 3.19175820 |
| 126 | aromatic amino acid family metabolic process (GO:0009072) | 3.17934208 |
| 127 | cellular ketone body metabolic process (GO:0046950) | 3.14097475 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.09750295 |
| 129 | protein-lipid complex assembly (GO:0065005) | 3.06352393 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.04950101 |
| 131 | protein localization to kinetochore (GO:0034501) | 2.95424560 |
| 132 | protein complex disassembly (GO:0043241) | 2.94444938 |
| 133 | translation (GO:0006412) | 2.92520571 |
| 134 | lipoxygenase pathway (GO:0019372) | 2.91688510 |
| 135 | neutrophil activation involved in immune response (GO:0002283) | 2.90957792 |
| 136 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.88021296 |
| 137 | multicellular organismal water homeostasis (GO:0050891) | 2.87293311 |
| 138 | keratinization (GO:0031424) | 2.86976101 |
| 139 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.86351387 |
| 140 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.86027897 |
| 141 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.84115868 |
| 142 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.82455163 |
| 143 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.81695093 |
| 144 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.80394910 |
| 145 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.80394910 |
| 146 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.79150319 |
| 147 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.79147653 |
| 148 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.79147653 |
| 149 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.79147653 |
| 150 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.78467110 |
| 151 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.78135904 |
| 152 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.76865967 |
| 153 | proteasome assembly (GO:0043248) | 2.76756259 |
| 154 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.76159547 |
| 155 | macromolecular complex disassembly (GO:0032984) | 2.74786747 |
| 156 | keratinocyte differentiation (GO:0030216) | 2.74160505 |
| 157 | neutrophil mediated immunity (GO:0002446) | 2.74055616 |
| 158 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.73882332 |
| 159 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.73882332 |
| 160 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.72845966 |
| 161 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.72063363 |
| 162 | positive regulation of chemokine secretion (GO:0090197) | 2.70574874 |
| 163 | reactive oxygen species biosynthetic process (GO:1903409) | 2.70544561 |
| 164 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.69736132 |
| 165 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.67970995 |
| 166 | keratinocyte proliferation (GO:0043616) | 2.64557153 |
| 167 | DNA strand elongation (GO:0022616) | 2.63481707 |
| 168 | kinetochore organization (GO:0051383) | 2.62462591 |
| 169 | DNA replication checkpoint (GO:0000076) | 2.62459083 |
| 170 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.60333362 |
| 171 | telomere maintenance via recombination (GO:0000722) | 2.60115490 |
| 172 | kinetochore assembly (GO:0051382) | 2.59787466 |
| 173 | mitotic metaphase plate congression (GO:0007080) | 2.59576293 |
| 174 | protein targeting to membrane (GO:0006612) | 2.58702338 |
| 175 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58584079 |
| 176 | * cyclooxygenase pathway (GO:0019371) | 2.58451893 |
| 177 | ribosome assembly (GO:0042255) | 2.57082055 |
| 178 | glucosamine-containing compound catabolic process (GO:1901072) | 2.54582598 |
| 179 | DNA deamination (GO:0045006) | 2.54259802 |
| 180 | hepatocyte apoptotic process (GO:0097284) | 2.49594280 |
| 181 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49514336 |
| 182 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.48087699 |
| 183 | negative regulation of ligase activity (GO:0051352) | 2.48087699 |
| 184 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.47835131 |
| 185 | positive regulation of cell cycle arrest (GO:0071158) | 2.45762596 |
| 186 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.45648058 |
| 187 | mitotic recombination (GO:0006312) | 2.42921769 |
| 188 | protein localization to chromosome, centromeric region (GO:0071459) | 2.40276733 |
| 189 | immunoglobulin mediated immune response (GO:0016064) | 2.38755198 |
| 190 | water homeostasis (GO:0030104) | 2.37060917 |
| 191 | leukotriene biosynthetic process (GO:0019370) | 2.35324020 |
| 192 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.34504663 |
| 193 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.34503616 |
| 194 | mRNA catabolic process (GO:0006402) | 2.33875456 |
| 195 | regulation of hypersensitivity (GO:0002883) | 2.33755846 |
| 196 | negative regulation of stress fiber assembly (GO:0051497) | 2.33572514 |
| 197 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.32940523 |
| 198 | epidermal cell differentiation (GO:0009913) | 2.32570654 |
| 199 | detection of other organism (GO:0098543) | 2.31532986 |
| 200 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.30486365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.15807501 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.40723012 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.61083852 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.91626469 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.58323298 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.26310512 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.26272517 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.79383569 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.59877600 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.05157155 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.00539498 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99202427 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.92774122 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90568044 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.88526724 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.60461576 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43874789 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.43656478 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.43206438 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.27921132 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.24204648 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.18310252 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17805850 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.16393131 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.02748286 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.96110318 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.95775255 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91902696 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88061825 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87727702 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.87064484 |
| 32 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.80056001 |
| 33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.75510203 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71968374 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.70628106 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.70569939 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67131789 |
| 38 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.66303039 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62470237 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59508874 |
| 41 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.55471109 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54762530 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.48869649 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.48751067 |
| 45 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.48751067 |
| 46 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.48751067 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47441499 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47433044 |
| 49 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45708186 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44969024 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44739151 |
| 52 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42213580 |
| 53 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42213580 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42037612 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41979862 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41475985 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40724998 |
| 58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.38327407 |
| 59 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37706770 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37188930 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35558735 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34894484 |
| 63 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.34865482 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34234984 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33430260 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32136341 |
| 67 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.31770599 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.30054780 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29460491 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28682460 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27643448 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26590295 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26246077 |
| 74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26067736 |
| 75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26067736 |
| 76 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25929684 |
| 77 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25793007 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24948264 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24472856 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24096825 |
| 81 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24036391 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23298266 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23141188 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22894537 |
| 85 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22115054 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22006765 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21809839 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.20505677 |
| 89 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18880293 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18128348 |
| 91 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16917072 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16635409 |
| 93 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16309613 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15883761 |
| 95 | CBP_21632823_ChIP-Seq_H3396_Human | 1.14898553 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13882622 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13872073 |
| 98 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13683202 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12817085 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12019829 |
| 101 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.11918038 |
| 102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10495704 |
| 103 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.10016273 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09833026 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09586958 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09437989 |
| 107 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08720885 |
| 108 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.08690512 |
| 109 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08144569 |
| 110 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06747747 |
| 111 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06546870 |
| 112 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05881078 |
| 113 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05693306 |
| 114 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.05319125 |
| 115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05173103 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04757908 |
| 117 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04705619 |
| 118 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04373319 |
| 119 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04132515 |
| 120 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03843074 |
| 121 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03416826 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02284003 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02075101 |
| 124 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01419146 |
| 125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.00208603 |
| 126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99648697 |
| 127 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99546903 |
| 128 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99138685 |
| 129 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98861577 |
| 130 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98861577 |
| 131 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98709538 |
| 132 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98535087 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98438400 |
| 134 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.98414604 |
| 135 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98263330 |
| 136 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98256699 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97614994 |
| 138 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96889253 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96693792 |
| 140 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96322500 |
| 141 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95826831 |
| 142 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95782978 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95333917 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94443309 |
| 145 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94182317 |
| 146 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94079403 |
| 147 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94073285 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93324374 |
| 149 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92446830 |
| 150 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91565693 |
| 151 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91413564 |
| 152 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90958000 |
| 153 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90650652 |
| 154 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89846019 |
| 155 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89453073 |
| 156 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89294398 |
| 157 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.89232437 |
| 158 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.88956036 |
| 159 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88927624 |
| 160 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88927624 |
| 161 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88911523 |
| 162 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88793398 |
| 163 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88723970 |
| 164 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88660491 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88489819 |
| 166 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87517845 |
| 167 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86927806 |
| 168 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.86753860 |
| 169 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.86632218 |
| 170 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86632218 |
| 171 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86351211 |
| 172 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85993902 |
| 173 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.85901921 |
| 174 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85574907 |
| 175 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.85564355 |
| 176 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84926074 |
| 177 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84799760 |
| 178 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84138835 |
| 179 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83965862 |
| 180 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.83153655 |
| 181 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82282773 |
| 182 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81138068 |
| 183 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79450683 |
| 184 | NFYA_21822215_ChIP-Seq_K562_Human | 0.78731538 |
| 185 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.78022574 |
| 186 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77426107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.79806502 |
| 2 | MP0005365_abnormal_bile_salt | 5.72949544 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.69669617 |
| 4 | MP0008004_abnormal_stomach_pH | 5.50136785 |
| 5 | MP0005360_urolithiasis | 5.47022119 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.64195318 |
| 7 | MP0003195_calcinosis | 4.50471993 |
| 8 | MP0002796_impaired_skin_barrier | 4.27399577 |
| 9 | MP0001666_abnormal_nutrient_absorption | 4.09402102 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 3.85109589 |
| 11 | MP0003252_abnormal_bile_duct | 3.61716589 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 3.57811430 |
| 13 | MP0003693_abnormal_embryo_hatching | 3.34191583 |
| 14 | MP0003941_abnormal_skin_development | 3.23909523 |
| 15 | MP0003868_abnormal_feces_composition | 3.14526957 |
| 16 | MP0005275_abnormal_skin_tensile | 3.00223212 |
| 17 | MP0005501_abnormal_skin_physiology | 2.84285516 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.64343920 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.61062579 |
| 20 | MP0005332_abnormal_amino_acid | 2.50680140 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 2.45703454 |
| 22 | MP0002060_abnormal_skin_morphology | 2.20069693 |
| 23 | MP0004381_abnormal_hair_follicle | 2.14068179 |
| 24 | MP0009697_abnormal_copulation | 2.13037922 |
| 25 | MP0001216_abnormal_epidermal_layer | 2.10127314 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.97777521 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.89018190 |
| 28 | MP0001873_stomach_inflammation | 1.87512984 |
| 29 | MP0005451_abnormal_body_composition | 1.86784707 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.86641736 |
| 31 | MP0004947_skin_inflammation | 1.85695279 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.83275219 |
| 33 | MP0002098_abnormal_vibrissa_morphology | 1.77952734 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.72863956 |
| 35 | MP0003436_decreased_susceptibility_to | 1.69325061 |
| 36 | MP0003186_abnormal_redox_activity | 1.64487743 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.64086058 |
| 38 | MP0000490_abnormal_crypts_of | 1.63895159 |
| 39 | MP0001764_abnormal_homeostasis | 1.62266447 |
| 40 | MP0010771_integument_phenotype | 1.55459804 |
| 41 | MP0003077_abnormal_cell_cycle | 1.55001026 |
| 42 | MP0000377_abnormal_hair_follicle | 1.54307842 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.48335324 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.48091930 |
| 45 | MP0000470_abnormal_stomach_morphology | 1.46203326 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.45785512 |
| 47 | MP0000647_abnormal_sebaceous_gland | 1.40331274 |
| 48 | MP0000609_abnormal_liver_physiology | 1.38849386 |
| 49 | MP0001243_abnormal_dermal_layer | 1.33361075 |
| 50 | MP0005408_hypopigmentation | 1.31454793 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.26793856 |
| 52 | MP0002009_preneoplasia | 1.26684085 |
| 53 | MP0004272_abnormal_basement_membrane | 1.26555422 |
| 54 | MP0009785_altered_susceptibility_to | 1.25119639 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.24631899 |
| 56 | MP0004264_abnormal_extraembryonic_tissu | 1.22962806 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.22806496 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.22703205 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.20426394 |
| 60 | MP0005023_abnormal_wound_healing | 1.19794213 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.19567671 |
| 62 | MP0009931_abnormal_skin_appearance | 1.15731079 |
| 63 | MP0002006_tumorigenesis | 1.14715729 |
| 64 | MP0006054_spinal_hemorrhage | 1.13260794 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.13119019 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.12808435 |
| 67 | MP0008932_abnormal_embryonic_tissue | 1.12353304 |
| 68 | MP0000858_altered_metastatic_potential | 1.11970249 |
| 69 | MP0003786_premature_aging | 1.11365305 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.10509248 |
| 71 | MP0003315_abnormal_perineum_morphology | 1.10415381 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.09565967 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 1.09241533 |
| 74 | MP0000516_abnormal_urinary_system | 1.09241533 |
| 75 | MP0001835_abnormal_antigen_presentation | 1.09222470 |
| 76 | MP0003718_maternal_effect | 1.07848929 |
| 77 | MP0002419_abnormal_innate_immunity | 1.06715943 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.05553874 |
| 79 | MP0001191_abnormal_skin_condition | 1.05112048 |
| 80 | MP0001853_heart_inflammation | 1.05089744 |
| 81 | MP0008057_abnormal_DNA_replication | 1.04728486 |
| 82 | MP0005025_abnormal_response_to | 1.04430698 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.03177583 |
| 84 | MP0002254_reproductive_system_inflammat | 1.02736392 |
| 85 | MP0010307_abnormal_tumor_latency | 1.02734533 |
| 86 | MP0005670_abnormal_white_adipose | 1.01753956 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.98022748 |
| 88 | MP0000367_abnormal_coat/_hair | 0.97892519 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92293940 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.92121780 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.91511745 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.89168927 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.89168927 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.88848856 |
| 95 | MP0003448_altered_tumor_morphology | 0.88661586 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.88386249 |
| 97 | MP0001542_abnormal_bone_strength | 0.87978013 |
| 98 | MP0002938_white_spotting | 0.87694978 |
| 99 | MP0002452_abnormal_antigen_presenting | 0.86685422 |
| 100 | MP0000350_abnormal_cell_proliferation | 0.86671456 |
| 101 | MP0005395_other_phenotype | 0.86102561 |
| 102 | MP0009840_abnormal_foam_cell | 0.85571619 |
| 103 | MP0008058_abnormal_DNA_repair | 0.84262270 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.84217522 |
| 105 | MP0000383_abnormal_hair_follicle | 0.84100103 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.83842235 |
| 107 | MP0003136_yellow_coat_color | 0.83785196 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.83338985 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.83129879 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.80978097 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.80267047 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.80213706 |
| 113 | MP0002132_abnormal_respiratory_system | 0.79956803 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.78956131 |
| 115 | MP0000427_abnormal_hair_cycle | 0.77745277 |
| 116 | MP0001661_extended_life_span | 0.77728923 |
| 117 | MP0002405_respiratory_system_inflammati | 0.77482807 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.76629198 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.75824830 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 0.74186440 |
| 121 | MP0001819_abnormal_immune_cell | 0.73287029 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.73068692 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.73005121 |
| 124 | MP0003011_delayed_dark_adaptation | 0.72746763 |
| 125 | MP0000598_abnormal_liver_morphology | 0.72611393 |
| 126 | MP0010368_abnormal_lymphatic_system | 0.72272657 |
| 127 | MP0001730_embryonic_growth_arrest | 0.71969164 |
| 128 | MP0000627_abnormal_mammary_gland | 0.71470149 |
| 129 | MP0001664_abnormal_digestion | 0.71467371 |
| 130 | MP0004133_heterotaxia | 0.71419880 |
| 131 | MP0008872_abnormal_physiological_respon | 0.71042285 |
| 132 | MP0009053_abnormal_anal_canal | 0.70997929 |
| 133 | MP0001756_abnormal_urination | 0.70626732 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.70467056 |
| 135 | MP0009780_abnormal_chondrocyte_physiolo | 0.69502245 |
| 136 | MP0004019_abnormal_vitamin_homeostasis | 0.69305583 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.68948348 |
| 138 | MP0000343_altered_response_to | 0.68388664 |
| 139 | MP0004147_increased_porphyrin_level | 0.67582554 |
| 140 | MP0002723_abnormal_immune_serum | 0.66013871 |
| 141 | MP0009642_abnormal_blood_homeostasis | 0.63598711 |
| 142 | MP0002090_abnormal_vision | 0.63403179 |
| 143 | MP0005187_abnormal_penis_morphology | 0.61656045 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.59689408 |
| 145 | MP0000538_abnormal_urinary_bladder | 0.59464696 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.55571557 |
| 147 | MP0006036_abnormal_mitochondrial_physio | 0.53594275 |
| 148 | MP0000462_abnormal_digestive_system | 0.51255478 |
| 149 | MP0005197_abnormal_uvea_morphology | 0.51067738 |
| 150 | MP0005248_abnormal_Harderian_gland | 0.50631874 |
| 151 | MP0002168_other_aberrant_phenotype | 0.49655754 |
| 152 | MP0000604_amyloidosis | 0.49091395 |
| 153 | MP0003119_abnormal_digestive_system | 0.48788908 |
| 154 | MP0002233_abnormal_nose_morphology | 0.48299896 |
| 155 | MP0000467_abnormal_esophagus_morphology | 0.47911409 |
| 156 | MP0002697_abnormal_eye_size | 0.45538844 |
| 157 | MP0001881_abnormal_mammary_gland | 0.45486575 |
| 158 | MP0008469_abnormal_protein_level | 0.44946573 |
| 159 | MP0006292_abnormal_olfactory_placode | 0.44563622 |
| 160 | MP0003283_abnormal_digestive_organ | 0.43821301 |
| 161 | MP0002282_abnormal_trachea_morphology | 0.42176355 |
| 162 | MP0005164_abnormal_response_to | 0.41431846 |
| 163 | MP0002295_abnormal_pulmonary_circulatio | 0.39818141 |
| 164 | MP0005266_abnormal_metabolism | 0.38400710 |
| 165 | MP0005448_abnormal_energy_balance | 0.37999615 |
| 166 | MP0009764_decreased_sensitivity_to | 0.37753965 |
| 167 | MP0002078_abnormal_glucose_homeostasis | 0.37489546 |
| 168 | MP0001293_anophthalmia | 0.36494672 |
| 169 | MP0001915_intracranial_hemorrhage | 0.36197386 |
| 170 | MP0003879_abnormal_hair_cell | 0.34701225 |
| 171 | MP0005551_abnormal_eye_electrophysiolog | 0.34533234 |
| 172 | MP0002837_dystrophic_cardiac_calcinosis | 0.34299520 |
| 173 | MP0000566_synostosis | 0.33526845 |
| 174 | MP0003959_abnormal_lean_body | 0.32437573 |
| 175 | MP0003953_abnormal_hormone_level | 0.31917649 |
| 176 | MP0005330_cardiomyopathy | 0.30789730 |
| 177 | MP0004043_abnormal_pH_regulation | 0.29971629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.10062171 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 7.75923994 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.09099321 |
| 4 | Conjugated hyperbilirubinemia (HP:0002908) | 5.94773627 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.78147316 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.51182643 |
| 7 | Complement deficiency (HP:0004431) | 5.46395222 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.41614012 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.31998749 |
| 10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.19953607 |
| 11 | Hypolipoproteinemia (HP:0010981) | 5.18790499 |
| 12 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.13699012 |
| 13 | Fat malabsorption (HP:0002630) | 5.04233964 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.98808842 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 4.84872215 |
| 16 | Reticulocytopenia (HP:0001896) | 4.67906147 |
| 17 | Steatorrhea (HP:0002570) | 4.51510353 |
| 18 | Abnormality of complement system (HP:0005339) | 4.33977123 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 4.18914038 |
| 20 | Increased IgE level (HP:0003212) | 4.15603090 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11726021 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 4.05637992 |
| 23 | Spontaneous abortion (HP:0005268) | 4.02599838 |
| 24 | Abnormality of proline metabolism (HP:0010907) | 3.90780665 |
| 25 | Hydroxyprolinuria (HP:0003080) | 3.90780665 |
| 26 | Xanthomatosis (HP:0000991) | 3.86138336 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.82080152 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.80203865 |
| 29 | Hyperglycinemia (HP:0002154) | 3.79141488 |
| 30 | Woolly hair (HP:0002224) | 3.68977427 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66799667 |
| 32 | Glomerulonephritis (HP:0000099) | 3.59995585 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 3.56118857 |
| 34 | Generalized aminoaciduria (HP:0002909) | 3.53223156 |
| 35 | Glycosuria (HP:0003076) | 3.51612834 |
| 36 | Abnormality of urine glucose concentration (HP:0011016) | 3.51612834 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.47478485 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 3.42835314 |
| 39 | Hyperglycinuria (HP:0003108) | 3.41091952 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33830289 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.33830289 |
| 42 | Hyperammonemia (HP:0001987) | 3.29094034 |
| 43 | Abnormality of methionine metabolism (HP:0010901) | 3.26430711 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.21047535 |
| 45 | Recurrent abscess formation (HP:0002722) | 3.20690234 |
| 46 | Abnormality of vitamin metabolism (HP:0100508) | 3.19739756 |
| 47 | Sparse eyelashes (HP:0000653) | 3.19565877 |
| 48 | Erythema (HP:0010783) | 3.18362019 |
| 49 | Macrocytic anemia (HP:0001972) | 3.17179583 |
| 50 | Vascular calcification (HP:0004934) | 3.14567696 |
| 51 | Trismus (HP:0000211) | 3.13506435 |
| 52 | Parakeratosis (HP:0001036) | 3.11961895 |
| 53 | Joint hemorrhage (HP:0005261) | 3.11643552 |
| 54 | Hypotrichosis (HP:0001006) | 3.09442781 |
| 55 | Erythroderma (HP:0001019) | 3.05981290 |
| 56 | Pustule (HP:0200039) | 3.05859546 |
| 57 | Proximal tubulopathy (HP:0000114) | 3.03154119 |
| 58 | Breast hypoplasia (HP:0003187) | 3.01326476 |
| 59 | Rickets (HP:0002748) | 3.01123056 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.89134295 |
| 61 | Multiple enchondromatosis (HP:0005701) | 2.87773559 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.85166067 |
| 63 | Nephritis (HP:0000123) | 2.81723677 |
| 64 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.76494094 |
| 65 | Congenital, generalized hypertrichosis (HP:0004540) | 2.74128425 |
| 66 | Obstructive lung disease (HP:0006536) | 2.72352184 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72352184 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.69664171 |
| 69 | Pallor (HP:0000980) | 2.67506599 |
| 70 | Vacuolated lymphocytes (HP:0001922) | 2.66521784 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.59277154 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.55729371 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53640995 |
| 74 | Abnormality of nail color (HP:0100643) | 2.49999321 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47616933 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.47418076 |
| 77 | Abnormal hemoglobin (HP:0011902) | 2.43557923 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42656757 |
| 79 | Metabolic acidosis (HP:0001942) | 2.42563194 |
| 80 | Palmoplantar hyperkeratosis (HP:0000972) | 2.42431171 |
| 81 | Lip pit (HP:0100267) | 2.41469843 |
| 82 | Lethargy (HP:0001254) | 2.40271545 |
| 83 | Epidermoid cyst (HP:0200040) | 2.38915269 |
| 84 | Premature ovarian failure (HP:0008209) | 2.36252648 |
| 85 | Onycholysis (HP:0001806) | 2.34965792 |
| 86 | Palmar hyperkeratosis (HP:0010765) | 2.32214769 |
| 87 | Plantar hyperkeratosis (HP:0007556) | 2.32119114 |
| 88 | Hypoglycemic coma (HP:0001325) | 2.30777360 |
| 89 | Abnormality of the umbilical cord (HP:0010881) | 2.30262771 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 2.27688900 |
| 91 | Petechiae (HP:0000967) | 2.26300209 |
| 92 | Urticaria (HP:0001025) | 2.26036567 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24703852 |
| 94 | Rough bone trabeculation (HP:0100670) | 2.24190045 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.24153122 |
| 96 | Gangrene (HP:0100758) | 2.24097002 |
| 97 | Malnutrition (HP:0004395) | 2.23756667 |
| 98 | Thrombocytosis (HP:0001894) | 2.21518732 |
| 99 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.19964210 |
| 100 | Single umbilical artery (HP:0001195) | 2.19964210 |
| 101 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.19964210 |
| 102 | Cerebral edema (HP:0002181) | 2.19388351 |
| 103 | Ureteral duplication (HP:0000073) | 2.19294155 |
| 104 | Poor head control (HP:0002421) | 2.16827824 |
| 105 | Mitral stenosis (HP:0001718) | 2.16720733 |
| 106 | Chromsome breakage (HP:0040012) | 2.16714111 |
| 107 | Absent thumb (HP:0009777) | 2.15090898 |
| 108 | Abnormal urine phosphate concentration (HP:0012599) | 2.15073819 |
| 109 | Megaloblastic anemia (HP:0001889) | 2.14926232 |
| 110 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.12967069 |
| 111 | Concave nail (HP:0001598) | 2.10925786 |
| 112 | Hypercholesterolemia (HP:0003124) | 2.10860268 |
| 113 | Osteomalacia (HP:0002749) | 2.08889964 |
| 114 | Interstitial pulmonary disease (HP:0006530) | 2.08190776 |
| 115 | Acute encephalopathy (HP:0006846) | 2.08086268 |
| 116 | Abnormality of the preputium (HP:0100587) | 2.06672046 |
| 117 | Blepharitis (HP:0000498) | 2.06153032 |
| 118 | Granulocytopenia (HP:0001913) | 2.05448839 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04847560 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 2.04847560 |
| 121 | Hyperalaninemia (HP:0003348) | 2.04847560 |
| 122 | Agnosia (HP:0010524) | 2.02037869 |
| 123 | Natal tooth (HP:0000695) | 2.01468686 |
| 124 | Skin ulcer (HP:0200042) | 1.99702075 |
| 125 | Ectropion (HP:0000656) | 1.99393009 |
| 126 | Eosinophilia (HP:0001880) | 1.99382990 |
| 127 | Nausea (HP:0002018) | 1.97995805 |
| 128 | Anhidrosis (HP:0000970) | 1.96660606 |
| 129 | Abnormal blistering of the skin (HP:0008066) | 1.96242432 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 1.95943902 |
| 131 | Microretrognathia (HP:0000308) | 1.95376416 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.94854925 |
| 133 | Cellulitis (HP:0100658) | 1.93793754 |
| 134 | Irritability (HP:0000737) | 1.93281202 |
| 135 | Cerebral palsy (HP:0100021) | 1.91865279 |
| 136 | Periodontitis (HP:0000704) | 1.88082293 |
| 137 | Nail dystrophy (HP:0008404) | 1.87959597 |
| 138 | Curly hair (HP:0002212) | 1.87320527 |
| 139 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87136410 |
| 140 | Prostate neoplasm (HP:0100787) | 1.86902743 |
| 141 | Bifid scrotum (HP:0000048) | 1.86697733 |
| 142 | Glossoptosis (HP:0000162) | 1.86580937 |
| 143 | Abnormality of purine metabolism (HP:0004352) | 1.85757923 |
| 144 | Degeneration of anterior horn cells (HP:0002398) | 1.85404061 |
| 145 | Abnormality of the anterior horn cell (HP:0006802) | 1.85404061 |
| 146 | Fasciculations (HP:0002380) | 1.84571598 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.84303081 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84303081 |
| 149 | Pili torti (HP:0003777) | 1.83958390 |
| 150 | Retinal atrophy (HP:0001105) | 1.82867557 |
| 151 | Sparse scalp hair (HP:0002209) | 1.81844745 |
| 152 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.81581501 |
| 153 | Cleft eyelid (HP:0000625) | 1.81250214 |
| 154 | Mediastinal lymphadenopathy (HP:0100721) | 1.80214537 |
| 155 | CNS demyelination (HP:0007305) | 1.79494828 |
| 156 | Enlarged kidneys (HP:0000105) | 1.79374902 |
| 157 | Pruritus (HP:0000989) | 1.78903533 |
| 158 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77606909 |
| 159 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77606909 |
| 160 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77606909 |
| 161 | Distal lower limb muscle weakness (HP:0009053) | 1.77553115 |
| 162 | Abnormal trabecular bone morphology (HP:0100671) | 1.77388910 |
| 163 | Gout (HP:0001997) | 1.76929481 |
| 164 | 11 pairs of ribs (HP:0000878) | 1.76794717 |
| 165 | Sepsis (HP:0100806) | 1.76301655 |
| 166 | Corneal erosion (HP:0200020) | 1.76232443 |
| 167 | Renal cortical cysts (HP:0000803) | 1.76103615 |
| 168 | Stenosis of the external auditory canal (HP:0000402) | 1.75586108 |
| 169 | Abnormality of glycolysis (HP:0004366) | 1.74475954 |
| 170 | Bile duct proliferation (HP:0001408) | 1.72205895 |
| 171 | Abnormal biliary tract physiology (HP:0012439) | 1.72205895 |
| 172 | Cheilitis (HP:0100825) | 1.71663381 |
| 173 | Hepatocellular carcinoma (HP:0001402) | 1.71658293 |
| 174 | Prolonged neonatal jaundice (HP:0006579) | 1.71405411 |
| 175 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71382466 |
| 176 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70301256 |
| 177 | Dicarboxylic aciduria (HP:0003215) | 1.70301256 |
| 178 | Colon cancer (HP:0003003) | 1.70125268 |
| 179 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69741556 |
| 180 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.69563859 |
| 181 | Villous atrophy (HP:0011473) | 1.69563859 |
| 182 | Carpal bone hypoplasia (HP:0001498) | 1.69419162 |
| 183 | Vomiting (HP:0002013) | 1.69024160 |
| 184 | Fragile nails (HP:0001808) | 1.68774306 |
| 185 | Absent radius (HP:0003974) | 1.67520618 |
| 186 | Acanthocytosis (HP:0001927) | 1.64581158 |
| 187 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.64106363 |
| 188 | Abnormal sex determination (HP:0012244) | 1.63836929 |
| 189 | Sex reversal (HP:0012245) | 1.63836929 |
| 190 | Ketosis (HP:0001946) | 1.62163434 |
| 191 | Elevated alkaline phosphatase (HP:0003155) | 1.61821044 |
| 192 | Hepatic necrosis (HP:0002605) | 1.61569053 |
| 193 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.60721845 |
| 194 | Fair hair (HP:0002286) | 1.60281504 |
| 195 | Alkalosis (HP:0001948) | 1.60214032 |
| 196 | Renal tubular dysfunction (HP:0000124) | 1.59767921 |
| 197 | Pancreatitis (HP:0001733) | 1.57833532 |
| 198 | Gingival bleeding (HP:0000225) | 1.57683933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.51331403 |
| 2 | EPHA2 | 3.06401191 |
| 3 | BUB1 | 3.00997464 |
| 4 | PIM2 | 3.00535368 |
| 5 | NME2 | 2.86228707 |
| 6 | PBK | 2.84604638 |
| 7 | WEE1 | 2.74603549 |
| 8 | MAP3K12 | 2.70187438 |
| 9 | RPS6KB2 | 2.69426687 |
| 10 | MST1R | 2.66048193 |
| 11 | MAPKAPK3 | 2.50236734 |
| 12 | WNK3 | 2.36627340 |
| 13 | IRAK3 | 2.21516168 |
| 14 | TESK1 | 2.18360825 |
| 15 | BMPR1B | 2.18028319 |
| 16 | STK10 | 2.05124400 |
| 17 | MAP3K3 | 1.78673927 |
| 18 | EIF2AK1 | 1.75983676 |
| 19 | LRRK2 | 1.74643893 |
| 20 | BLK | 1.72072677 |
| 21 | ERBB4 | 1.71311651 |
| 22 | MAP3K11 | 1.63861244 |
| 23 | NEK2 | 1.54999017 |
| 24 | EIF2AK3 | 1.53598217 |
| 25 | SRPK1 | 1.47449091 |
| 26 | TTK | 1.37883008 |
| 27 | TNIK | 1.36372827 |
| 28 | RPS6KA4 | 1.35361143 |
| 29 | TRIM28 | 1.29860898 |
| 30 | AURKB | 1.25309734 |
| 31 | NEK9 | 1.23672093 |
| 32 | TRPM7 | 1.22929293 |
| 33 | CASK | 1.22846634 |
| 34 | CDC7 | 1.19113214 |
| 35 | STK38L | 1.17691157 |
| 36 | OXSR1 | 1.16508751 |
| 37 | STK39 | 1.16422179 |
| 38 | PIM1 | 1.15841011 |
| 39 | MAP3K14 | 1.12718674 |
| 40 | PRKCE | 1.11742987 |
| 41 | MAP3K8 | 1.10971166 |
| 42 | NEK1 | 1.10850772 |
| 43 | IRAK4 | 1.09825795 |
| 44 | ACVR1B | 1.07931754 |
| 45 | RIPK4 | 1.07879552 |
| 46 | EIF2AK2 | 1.07601659 |
| 47 | BCKDK | 1.06440226 |
| 48 | AURKA | 1.05450238 |
| 49 | MUSK | 1.03969860 |
| 50 | FRK | 1.02538101 |
| 51 | CDK7 | 1.02477479 |
| 52 | MAP2K3 | 1.01240034 |
| 53 | PRKG2 | 1.01082229 |
| 54 | STK4 | 1.00266551 |
| 55 | TAOK2 | 1.00223888 |
| 56 | STK16 | 1.00055862 |
| 57 | BRSK2 | 0.99455613 |
| 58 | PLK4 | 0.99271544 |
| 59 | ADRBK2 | 0.99106887 |
| 60 | PLK1 | 0.98765053 |
| 61 | TBK1 | 0.98371965 |
| 62 | FER | 0.96219411 |
| 63 | ABL2 | 0.95361991 |
| 64 | PAK4 | 0.95267115 |
| 65 | LMTK2 | 0.87411506 |
| 66 | PRKCI | 0.87118443 |
| 67 | ERN1 | 0.86791503 |
| 68 | PTK2 | 0.85764436 |
| 69 | IKBKB | 0.84822615 |
| 70 | FLT3 | 0.84723394 |
| 71 | TIE1 | 0.84394031 |
| 72 | ARAF | 0.82133318 |
| 73 | DDR2 | 0.81983150 |
| 74 | ZAK | 0.81665531 |
| 75 | TLK1 | 0.81573406 |
| 76 | TGFBR2 | 0.80976788 |
| 77 | INSRR | 0.79663059 |
| 78 | MYLK | 0.79556625 |
| 79 | EPHA4 | 0.79501063 |
| 80 | MET | 0.78496945 |
| 81 | EPHB2 | 0.78236651 |
| 82 | TESK2 | 0.78135469 |
| 83 | BCR | 0.77989549 |
| 84 | PDK2 | 0.77858581 |
| 85 | MAP4K2 | 0.76226643 |
| 86 | PNCK | 0.76173417 |
| 87 | ERBB3 | 0.75895049 |
| 88 | LIMK1 | 0.75128868 |
| 89 | PRKCG | 0.73555474 |
| 90 | BRAF | 0.72995619 |
| 91 | PIK3CG | 0.72259617 |
| 92 | MAP2K2 | 0.70969222 |
| 93 | PIK3CA | 0.70022485 |
| 94 | MAP3K2 | 0.67363808 |
| 95 | PAK3 | 0.66867472 |
| 96 | PINK1 | 0.64859589 |
| 97 | STK24 | 0.63246796 |
| 98 | CDK6 | 0.62784581 |
| 99 | VRK2 | 0.62548798 |
| 100 | PAK1 | 0.62333250 |
| 101 | ZAP70 | 0.61902999 |
| 102 | PRKAA2 | 0.61695623 |
| 103 | CDK4 | 0.61682713 |
| 104 | LATS1 | 0.61045856 |
| 105 | NUAK1 | 0.59928603 |
| 106 | VRK1 | 0.59911973 |
| 107 | PRKACG | 0.59202905 |
| 108 | MAPKAPK2 | 0.58966260 |
| 109 | SCYL2 | 0.58430915 |
| 110 | MATK | 0.57693658 |
| 111 | NLK | 0.54687534 |
| 112 | MAP3K5 | 0.54508385 |
| 113 | LATS2 | 0.53944342 |
| 114 | DYRK3 | 0.53565880 |
| 115 | GRK1 | 0.53480603 |
| 116 | EEF2K | 0.52707346 |
| 117 | PLK2 | 0.52097360 |
| 118 | IGF1R | 0.51998379 |
| 119 | TEC | 0.51201624 |
| 120 | STK3 | 0.50889085 |
| 121 | WNK4 | 0.50794784 |
| 122 | MELK | 0.48912468 |
| 123 | ILK | 0.48050188 |
| 124 | CHEK2 | 0.47613707 |
| 125 | RPS6KA6 | 0.47263844 |
| 126 | PTK6 | 0.47177119 |
| 127 | CDK8 | 0.47170796 |
| 128 | RPS6KC1 | 0.46237718 |
| 129 | RPS6KL1 | 0.46237718 |
| 130 | FGFR1 | 0.46215692 |
| 131 | DAPK3 | 0.45454046 |
| 132 | ATR | 0.44898870 |
| 133 | CAMK2D | 0.44608091 |
| 134 | MKNK2 | 0.44595942 |
| 135 | CAMK2G | 0.43412448 |
| 136 | PDGFRA | 0.42100526 |
| 137 | PRKCA | 0.41283065 |
| 138 | PLK3 | 0.39620371 |
| 139 | ADRBK1 | 0.38217453 |
| 140 | CSNK1A1 | 0.37316341 |
| 141 | GRK6 | 0.37161061 |
| 142 | CSNK2A1 | 0.36728597 |
| 143 | TAOK1 | 0.35791344 |
| 144 | PRKCD | 0.35468202 |
| 145 | AKT3 | 0.34902345 |
| 146 | PDK3 | 0.32987027 |
| 147 | PDK4 | 0.32987027 |
| 148 | IKBKE | 0.32644730 |
| 149 | ERBB2 | 0.32445356 |
| 150 | TGFBR1 | 0.32313434 |
| 151 | TYK2 | 0.32105704 |
| 152 | BMX | 0.31178186 |
| 153 | GRK7 | 0.29608604 |
| 154 | RIPK1 | 0.28447061 |
| 155 | CSNK1G1 | 0.28097386 |
| 156 | PRKACA | 0.27996592 |
| 157 | CSNK2A2 | 0.27325014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.44274752 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.00379013 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.97774116 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.64293921 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.38094162 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 3.04912192 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.79330138 |
| 8 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.63189834 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46660504 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.44346453 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39388842 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.24658321 |
| 13 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.21546227 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 2.19435833 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.13122590 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06561212 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.06027296 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04135780 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01533409 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.00809941 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00659236 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.96859603 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.91896932 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85739518 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83454873 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83346907 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.82871318 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.78281429 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.78111981 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78001755 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.73216592 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.68113147 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.62657400 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.60427996 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 1.59455884 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.57016639 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54193484 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.52911697 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51152919 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.48753091 |
| 41 | Cell cycle_Homo sapiens_hsa04110 | 1.44819082 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44313005 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41905254 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.39549422 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38006928 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.37221728 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33656430 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33647974 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32503997 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32424106 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.32262118 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27525275 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27170481 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23372043 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21429504 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19857289 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18204561 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17048534 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16802388 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.16442269 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15379099 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.14174092 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13512139 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 1.13130661 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11441289 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09227146 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03389024 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02010182 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01258718 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01025367 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99636726 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99137307 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99046405 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97231343 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.97213902 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96844709 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96809890 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95650015 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94190174 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.92591625 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.90541080 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.86244940 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86159274 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85890638 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83998678 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81214285 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.80514863 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80375617 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80117775 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79882363 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79592971 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75958576 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75008715 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74456249 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74106635 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.74057919 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.73810010 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.73424264 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71296797 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.71213350 |
| 101 | Tuberculosis_Homo sapiens_hsa05152 | 0.71173005 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70193803 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70052557 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67434843 |
| 105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.66596236 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66368999 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65936898 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.65270524 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64178757 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.61959276 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.61337725 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60835851 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59125134 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57257753 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.56650511 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.56413952 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55847474 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55249721 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54364414 |
| 120 | Malaria_Homo sapiens_hsa05144 | 0.54281910 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53141826 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50958727 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50253092 |
| 124 | Protein export_Homo sapiens_hsa03060 | 0.48966005 |
| 125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46890175 |
| 126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46446156 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45243846 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | 0.44461019 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44387921 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.43665360 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43214681 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42710103 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41925364 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41493097 |
| 135 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41345948 |
| 136 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40754772 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40163816 |
| 138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39958982 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.39431518 |
| 140 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39345223 |
| 141 | Measles_Homo sapiens_hsa05162 | 0.38199629 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37586285 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.36690342 |
| 144 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36638505 |
| 145 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.36633259 |
| 146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36402479 |
| 147 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36367763 |
| 148 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34169602 |
| 149 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33029216 |
| 150 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19353059 |
| 151 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.14237029 |
| 152 | Parkinsons disease_Homo sapiens_hsa05012 | 0.12807502 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12308545 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.11427461 |
| 155 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09262603 |
| 156 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.09036935 |
| 157 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.04359116 |
| 158 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.02543664 |
| 159 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01518943 |
| 160 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0679417 |
| 161 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0651443 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0401275 |
| 163 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0296062 |
| 164 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0232930 |

